Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo.

Rupp J, Hellwig-Burgel T, Wobbe V, Seitzer U, Brandt E, Maass M.

Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3447-52. Epub 2005 Feb 18.

2.

Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway.

Bea F, Puolakkainen MH, McMillen T, Hudson FN, Mackman N, Kuo CC, Campbell LA, Rosenfeld ME.

Circ Res. 2003 Mar 7;92(4):394-401. Epub 2003 Feb 6.

PMID:
12600889
3.

Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae.

Kern JM, Maass V, Rupp J, Maass M.

Thromb Haemost. 2009 Oct;102(4):743-53. doi: 10.1160/TH09-02-0128.

PMID:
19806261
5.

Stretch-inducible expression of the angiogenic factor CCN1 in vascular smooth muscle cells is mediated by Egr-1.

Grote K, Bavendiek U, Grothusen C, Flach I, Hilfiker-Kleiner D, Drexler H, Schieffer B.

J Biol Chem. 2004 Dec 31;279(53):55675-81. Epub 2004 Oct 18.

6.

Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor.

Gencay MM, Tamm M, Glanville A, Perruchoud AP, Roth M.

Infect Immun. 2003 Oct;71(10):5814-22.

7.

Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae.

Maass M, Gieffers J, Solbach W.

Herz. 2000 Mar;25(2):68-72.

PMID:
10829241
8.

In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells.

Quinn TC, Gaydos CA.

Am Heart J. 1999 Nov;138(5 Pt 2):S507-11.

PMID:
10539860
10.
11.

Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain?

Di Pietro M, Filardo S, Cazzavillan S, Segala C, Bevilacqua P, Bonoldi E, D'Amore ES, Rassu M, Sessa R.

J Biol Regul Homeost Agents. 2013 Jan-Mar;27(1):155-64.

PMID:
23489695
12.

Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection.

Peters J, Hess S, Endlich K, Thalmann J, Holzberg D, Kracht M, Schaefer M, Bartling G, Klos A.

Cell Microbiol. 2005 Aug;7(8):1099-108.

PMID:
16008577
13.

Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.

Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG, Van Waes C, Chen Z.

Cancer Res. 2005 Aug 15;65(16):7071-80.

14.

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.

Gieffers J, F├╝llgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, Solbach W, Maass M.

Circulation. 2001 Jan 23;103(3):351-6.

PMID:
11157684
15.

Chlamydia pneumoniae adversely modulates vascular cell properties by direct interaction with signalling cascades.

Kern JM, Maass V, Maass M.

Thromb Haemost. 2009 Dec;102(6):1064-70. doi: 10.1160/TH09-06-0348. Review.

PMID:
19967136
16.

Oxidized LDL promotes the mitogenic actions of Chlamydia pneumoniae in vascular smooth muscle cells.

Chahine MN, Deniset J, Dibrov E, Hirono S, Blackwood DP, Austria JA, Pierce GN.

Cardiovasc Res. 2011 Dec 1;92(3):476-83. doi: 10.1093/cvr/cvr251.

PMID:
22072707
17.

Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation.

Miller SA, Selzman CH, Shames BD, Barton HA, Johnson SM, Harken AH.

J Surg Res. 2000 May 1;90(1):76-81.

PMID:
10781378
18.

Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells.

Yang X, Coriolan D, Schultz K, Golenbock DT, Beasley D.

Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2308-14. Epub 2005 Sep 22.

PMID:
16179594
19.

Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells.

Molestina RE, Miller RD, Lentsch AB, Ramirez JA, Summersgill JT.

Infect Immun. 2000 Jul;68(7):4282-8.

Supplemental Content

Support Center